Affordable Access

deepdyve-link
Publisher Website

Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma.

Authors
  • Wang, Jia1, 2
  • Zuo, Jie3
  • Wang, Mao-De1, 2
  • Xie, Wan-Fu1
  • Bai, Xiao-Bin1
  • Ma, Xu-Dong1
  • 1 Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. , (China)
  • 2 Center of Brain Science, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. , (China)
  • 3 The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. , (China)
Type
Published Article
Journal
CNS Neuroscience & Therapeutics
Publisher
Wiley (Blackwell Publishing)
Publication Date
Jul 01, 2020
Volume
26
Issue
7
Pages
777–777
Identifiers
DOI: 10.1111/cns.13227
PMID: 31578804
Source
Medline
Language
English
License
Unknown

Abstract

Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma, CNS Neuroscience & Therapeutics 2019, (https://doi.org/10.1111/cns.13227). The above article published online on 02 October 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor in Chief Jun Chen, and John Wiley & Sons Ltd. The retraction has been agreed due to unreliable data and consequently its misleading results and conclusions. © 2020 The Authors. CNS Neuroscience & Therapeutics Published by John Wiley & Sons Ltd.

Report this publication

Statistics

Seen <100 times